Inclusive of all taxes
50 mg Fluvoxamine Tablets IP 50 mg is a high-quality pharmaceutical formulation specifically designed for the effective management of neurology and psychiatry disorders. Manufactured under stringent export-grade standards, this product ensures precise dosage, safety, and therapeutic efficacy. Each tablet contains 50 mg of the active ingredient Fluvoxamine, widely prescribed for conditions such as obsessive-compulsive disorder (OCD), depression, and other related psychiatric ailments. Produced in GMP-compliant facilities by IndiGlobal Exports, these tablets meet international pharmacopoeial standards (IP/USP) and are packaged in secure blister or strip packs, making them suitable for global markets including regulated and semi-regulated territories. The product’s consistent therapeutic performance and compliance with global healthcare regulations make it an ideal choice for hospital pharmacies, institutional buyers, and pharmaceutical distributors seeking reliable neuropsychiatric medication solutions.
Key Features
| Features | Description |
|---|---|
| Dosage | 50 mg Fluvoxamine per tablet |
| Therapeutic Use | Management of neurology and psychiatry conditions including OCD and depression |
| Formulation Type | Tablet |
| Manufacturing Standard | Produced in WHO-GMP compliant facilities |
| Packaging | Export-grade blister or strip packs |
| Quality Compliance | Meets IP and USP pharmacopoeial standards |
| Manufacturer | IndiGlobal Exports |
| Market Suitability | Approved for regulated and semi-regulated international pharmaceutical markets |
| Shelf Life | As per regulatory standards |
| Attributes | Description |
|---|---|
| Active Ingredient | Fluvoxamine 50 mg |
| Therapeutic Category | Neurology & Psychiatry |
| Dosage Form | Tablet |
| Packaging Type | Blister/Strip Pack |
| Production Facility | WHO-GMP certified |
| Pharmacopoeia Compliance | Indian Pharmacopoeia (IP) and United States Pharmacopeia (USP) |
| Intended Use | Prescription use for treatment of psychiatric disorders |
| Shelf Life | As per regulatory requirements |
| Export Classification | Export-quality pharmaceutical product |
| Manufacturer | IndiGlobal Exports |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, the 50 mg Fluvoxamine Tablets IP comply with WHO-GMP manufacturing standards and pharmacopoeial quality requirements (IP/USP), making them suitable for export to regulated European markets.
The tablets are packaged in export-grade blister or strip packs designed for bulk supply and institutional distribution, ensuring product integrity during transit and storage.
Yes, the 50 mg Fluvoxamine Tablets meet both Indian Pharmacopoeia (IP) and United States Pharmacopeia (USP) standards, ensuring consistent quality and safety.
Yes, this product is intended for prescription use and is widely used in hospital settings and retail pharmacies for the management of psychiatric disorders.
IndiGlobal Exports manufactures these tablets in WHO-GMP-certified facilities with rigorous quality control to ensure consistent therapeutic efficacy and compliance with global healthcare regulations.
Brand: indiglobal exports
Country Of Origin: India
50 mgFluvoxamine Tablets IP 50 mg is a pharmaceutical product indicated for neurology&psychiatry treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:50 mgFluvoxamine Tablets IP 50 mg is developed for the effective management of neurology&psychiatry conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with neurology&psychiatry indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
